Key Takeaways:
Johnson Fistel opened a securities fraud probe into Blaize Holdings (NASDAQ: BZAI) on Aug. 14 following a 68 percent revenue guidance cut, examining whether the AI computing company and certain executives violated federal securities laws.
The company's CFO said several commercial opportunities "did not materialize as we expected" and that management had planned on "a regular cadence of purchase orders from customers already under contract," according to the Aug. 13 earnings call. Blaize reduced full-year revenue guidance from $130 million to $40-$43 million, a roughly 68 percent cut at the midpoint.
Blaize's Form 10-Q disclosed that customer Starshine issued only one $10.4 million purchase order, of which $8.8 million remained unpaid. The receivable was transferred to Blaize's wholly owned Chinese subsidiary, with a third-party collections agent pursuing payment. Management fully reserved the receivable and said it would not engage further with Starshine unless the outstanding balance was paid.
Regarding NeoTensr, a previous $23.8 million receivable was paid in full, and management said second-quarter revenue "was driven by our momentum with NeoTensr." However, the April 2026 agreement for up to $50 million remained subject to NeoTensr issuing purchase orders. As of Aug. 13, NeoTensr had issued one $13.7 million purchase order, and the agreement was amended Aug. 7 to establish a take-or-pay arrangement with a minimum purchase commitment.
Blaize also said it no longer considered its previously reported pipeline metrics to be key business metrics after determining they were "not as closely connected with future revenue as previously expected."
Following the disclosures, Blaize shares traded below $0.64 on Aug. 14, more than 65 percent below the May public offering price of $1.85. The company raised approximately $35 million in gross proceeds from that offering of 18,918,918 shares.
A federal securities class action, Daniel v. Blaize Holdings, was filed Aug. 4 in the U.S. District Court for the Central District of California, covering investors who acquired Blaize securities between July 18, 2025, and April 28, 2026. The lead plaintiff deadline is Oct. 5, 2026. The complaint follows a short-seller report from Pelican Way Research published April 28 that questioned Blaize's relationship with NeoTensr, sending shares down 12 percent to $1.90.
Multiple firms including Rosen Law Firm, Robbins LLP, and Glancy Prongay Wolke & Rotter have issued notices to BZAI investors. The investigation and litigation come as the AI edge-computing sector faces scrutiny over revenue reliability from customer concentration. Investors will watch for further disclosures from Blaize and the outcome of the Oct. 5 lead plaintiff deadline.
This article is for informational purposes only and does not constitute investment advice.
